Dr. Marek Dziki, is a medical doctor with a PhD from the University in Lublin, Poland. In 1998 he completed his MBA at the International Business School in Warsaw and in 2005 completed another MBA from Merck University (Kellog Business School, Chicago, Hong Kong University of Science and Technology and Business School in Fountaineblue.
Dr. Dziki has extensive experience in Pharmaceuticals, Chemicals, Life Science, Bioscience, Research & Development and Clinical Research Development. He started his career in with Merck in 1992. Between 1992 and 2000, he worked with Merck Poland, between 2001 and 2005 with Merck Austria, between 2005 and 2006 with Merck Darmstadt and from 2006 to 2012 was the Managing Director of Merck India. After leaving Merck, Dr Dziki was appointed as an executive director in Skolkovo Innovation Centre in Moscow working in close collaboration with the governmental institutions for the transfer of technology to Russia and for the development of strategy for the Russian biopharma development. Dr Dziki joined Lumedan (Zurich, Odessa and Moscow) as the CEO in 2013 and by 2015 became a consultant thereto. From March 2014, Dr. Dziki, is the President and Founder of M&M Pharma, Warsaw, a company dealing with disruptive innovation in new technology, emerging markets and financing. In February 2016, Dr Dziki was appointed as a Member of the Managing Board of Bioton S.A. overseeing all commercial operations.